CYP4Z1-IN-1
CYP4Z1-IN-1 (compound 7c) is a potent CYP4Z1 inhibitor, with an IC50 of 41.8 nM. CYP4Z1-IN-1 decreases the expression of breast CSCs stemness markers, spheroid formation, and metastatic ability as well as tumor-initiation capability in a concentration-dependent manner in vitro and in vivo.
For research use only. We do not sell to patients.
- CAS No.: 2760611-38-7
- Formula: C13H18N2O3
- Molecular Weight:250.29
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
CYP4Z1 41.8 ± 1.4 nM (IC50) |
CYP4F11 291.3 ± 46 nM (IC50) |
CYP4F12 1598.3 ± 5 nM (IC50) |
CYP2D6 >10 000 nM (IC50) |
CYP2C9 >10 000 nM (IC50) |
CYP3A4 >10 000 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MCF7 | IC50 |
483 nM
Compound: 7c
|
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 36414390] |
| MDA-MB-231 | IC50 |
483 nM
Compound: 7c
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 36414390] |
CYP4Z1-IN-1 (compound 7c) shows antiproliferative activity against breast CSCs (cancer stem cells), with an IC50 of 483 ± 2.5 nM[1].
CYP4Z1-IN-1 (0.8-51.2 μM, 24 h) suppresses the expression of stemness markers (P-gp, Oct3/4, Nanog, ALDH1A1, and Sox2) in breast cancer cells[1].
CYP4Z1-IN-1 (0.8-51.2 μM, 24-48 h) attenuates the migration and invasion ability of breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 and MDA-MB-231 cells
-
Concentration:0.8 μM, 3.2 μM, 12.8 μM, 51.2 μM
-
Incubation Time:24 h
-
Result:Significantly suppressed the protein expression of stemness markers (P-gp, Oct3/4, Nanog, ALDH1A1, and Sox2) in MCF-7 cells in a concentration-dependent manner.
CYP4Z1-IN-1 (MCF-7 and MDA-MB-231 cells (12.8 μM, 72 h) implanted in the inguinal mammary gland of mice subcutaneously) blocks the tumor-initiating ability of breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mice[1]
-
Dosage:2000 mg/kg
-
Administration:orally, for 7 days
-
Result:Showed that compound 7c was rather safe; no evident toxicity and body weight loss were observed.
-
Animal Model:BALB/c-nude mice (3-4 week old, female)[1]
-
Dosage:12.8 μM
-
Administration:MCF-7 and MDA-MB-231 cells were pre-treated with 7c (12.8 μM) for 72 h and were then implanted in the inguinal mammary gland of mice subcutaneously
-
Result:Blocked the tumor-initiating ability of breast cancer cells.
Chemical Information
-
CAS No. 2760611-38-7
-
Molecular Weight 250.29
-
Formula C13H18N2O3
-
SMILES
O=C(CCCC1=CC=C(C=C1)N/C=N/O)OCC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CYP4Z1-IN-1 Related Classifications
HY-152159 Related Classifications
Powered by Bioz